Agroclavine 是 D1-多巴胺受体 (D1-dopamine receptor) 和 α1-肾上腺素能受体 (α1-adrenergic receptor) 激动剂,可增强脑对磁场的敏感性,损害空间记忆但不影响海马长时程增强 (LTP),并具有双向调节免疫活性:在正常状态下增强 NK 细胞活性且毒性低,在应激状态下则抑制 NK 细胞活性并表现出显著的心脏和肝脏毒性,因此可用于研究神经电生理、学习记忆和免疫调节。
产品编号: MS-C67858 CAS No.: 548-42-5 分子式: C16H18N2 分子量: 238.33
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
1mg
询价
3-5 天
5mg
询价
询价
10mg
询价
询价

产品描述

Agroclavine 是 D1-多巴胺受体 (D1-dopamine receptor) 和 α1-肾上腺素能受体 (α1-adrenergic receptor) 激动剂,可增强脑对磁场的敏感性,损害空间记忆但不影响海马长时程增强 (LTP),并具有双向调节免疫活性:在正常状态下增强 NK 细胞活性且毒性低,在应激状态下则抑制 NK 细胞活性并表现出显著的心脏和肝脏毒性,因此可用于研究神经电生理、学习记忆和免疫调节。

生物实验数据

生物活性 Agroclavine is an agonist of the D1-dopamine receptor and the α1-adrenergic receptor that enhances the brain's sensitivity to magnetic fields, impairs spatial memory without affecting hippocampal long-term potentiation (LTP), and exhibits bidirectional immunomodulatory activity by enhancing NK cell activity with low toxicity under normal conditions while suppressing NK cell activity and showing significant cardiac and hepatic toxicity under stress, making it useful for studying neuroelectrophysiology, learning and memory, and immune regulation.
IC50 & Target

D1 Receptor

 

α1-adrenergic receptor

 

体外研究
(In Vitro)

Agroclavine 对 L5178y 小鼠淋巴瘤细胞具有细胞抑制活性,其 EC50 为 6.3 μM。
Agroclavine (0.01-0.1 μM) 可增强 NK 细胞活性,提升白细胞介素-2 和干扰素-γ 的产生。

体内研究
(In Vivo)

Agroclavine (50 μg/kg; i.p.; 单次给药) 可诱导大鼠出现空间记忆损伤,且不会改变海马 CA1 区的长时程增强。
Agroclavine (50 μg/kg; i.p.; 单次给药) 可改变健康大鼠的皮层和海马脑电活动,并在联合磁场暴露后增强海马 β2 活动出现显著且持续性的升高。
Agroclavine (0.05-0.5 mg/kg; i.p.; 单次给药) 可显著提高无应激正常大鼠的脾脏 NK 细胞活性及血清 CKMB 水平;显著降低应激状态大鼠的脾脏 NK 细胞活性。

Animal Model: Wistar rats (male, 300-360 g)
Dosage: 50 μg/kg
Administration: i.p.; single dose
Result: Significantly increased delta (0.5-3.5 Hz) EEG activity in both the cortex and hippocampus during the first 30 minutes post-injection, with a larger effect in the cortex.
Decreased alpha (7.6-12.5 Hz) EEG activity in both the cortex and hippocampus, and decreased beta1 (12.6-17.5 Hz) activity in both regions, with a significantly greater attenuation in the cortex than the hippocampus.
Produced a significant increase in hippocampal beta2 activity, with only a non-significant trend toward increased beta2 activity in the cortex.
Potentiated an immediate, robust increase in hippocampal beta2 (22.5-30.5 Hz) activity relative to pre-exposure levels when combined with CMF exposure starting 1 hour post-injection; this effect persisted throughout the 30-minute post-exposure period, with a 46.3% increase in beta2 activity relative to pre-exposure values.
Did not produce significant changes in cortical EEG in agroclavine-pretreated rats during CMF exposure.
Animal Model: Wistar-Kyoto (3-month-old male, 230-280 g)
Dosage: 0.05 mg/kg; 0.5 mg/kg
Administration: i.p.; single dose
Result: Caused a moderate, non-significant increase in spleen NK cell activity at 0.05 mg/kg.
Caused a significant increase in spleen NK cell activity at 0.5 mg/kg.
Showed no significant effect on serum CKMB at 0.05 mg/kg.
Caused a significant increase in serum CKMB at 0.5 mg/kg.
Had no effect on serum ALT at both 0.05 mg/kg and 0.5 mg/kg.
Animal Model: Wistar-Kyoto (3-month-old male, 230-280 g; restraint and immersion in 23°C water stress model)
Dosage: 0.05 mg/kg; 0.5 mg/kg
Administration: i.p.; single dose; 30 min pre-stress
Result: Caused a significant decrease in spleen NK cell activity at 0.05 mg/kg compared to stressed control rats.
Caused a significant decrease in spleen NK cell activity at 0.5 mg/kg compared to stressed control rats.
Showed no significant effect on serum CKMB and ALT levels at 0.05 mg/kg relative to stressed controls.
Caused a more than twofold significant increase in serum CKMB at 0.5 mg/kg compared to stressed control rats.
Caused a significant increase in serum ALT at 0.5 mg/kg compared to stressed control rats.
性状 固体
颜色 Off-white to light brown

化学信息

分子量 238.33
分子式 C16H18N2
CAS No. 548-42-5

储存&溶解度

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础